We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDB icon
501
HDFC Bank
HDB
$123B
$2.37M 0.02%
72,980
-28,358
-28% -$993K
ZM icon
502
Zoom
ZM
$27B
$2.36M 0.02%
12,838
+1,037
+9% +$244K
ETR icon
503
Entergy
ETR
$51.3B
$2.35M 0.02%
17,558
-6,760
-28% -$355K
KHC icon
504
Kraft Heinz
KHC
$32.9B
$2.35M 0.02%
65,439
-2,022
-3% -$72.7K
APH icon
505
Amphenol
APH
$188B
$2.34M 0.01%
53,462
-15,764
-23% -$638K
MPC icon
506
Marathon Petroleum
MPC
$90.3B
$2.31M 0.01%
36,084
+867
+2% +$55.7K
O icon
507
Realty Income
O
$61.4B
$2.31M 0.01%
32,252
+9,650
+43% +$664K
LKQ icon
508
LKQ Corp
LKQ
$6.79B
$2.3M 0.01%
38,334
+1,866
+5% +$105K
HIG icon
509
Hartford Financial Services
HIG
$39.8B
$2.3M 0.01%
33,254
-2,594
-7% -$183K
SPY icon
510
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$2.24M 0.01%
5,362
-568,638
-99% -$261M
CTLT
511
DELISTED
CATALENT, INC.
CTLT
$2.22M 0.01%
9,626
-160
-2% -$20.6K
ORLY icon
512
O'Reilly Automotive
ORLY
$75.3B
$2.2M 0.01%
46,785
-10,980
-19% -$475K
SIVB
513
DELISTED
SVB Financial Group
SIVB
$2.2M 0.01%
3,245
-78
-2% -$54.9K
SNBR
514
DELISTED
Sleep Number
SNBR
$2.2M 0.01%
28,699
-6,573
-19% -$551K
MDB icon
515
MongoDB
MDB
$25.8B
$2.19M 0.01%
4,147
-8
-0.2% -$4.1K
VLO icon
516
Valero Energy
VLO
$90.3B
$2.17M 0.01%
28,963
-2,376
-8% -$177K
MLAB icon
517
Mesa Laboratories
MLAB
$545M
$2.16M 0.01%
6,597
TRN icon
518
Trinity Industries
TRN
$2.99B
$2.16M 0.01%
+71,531
New +$2.04M
PXD
519
DELISTED
Pioneer Natural Resource Co.
PXD
$2.16M 0.01%
11,858
+1,145
+11% +$211K
GLW icon
520
Corning
GLW
$109B
$2.15M 0.01%
57,789
-2,479
-4% -$92.8K
XRAY icon
521
Dentsply Sirona
XRAY
$2.76B
$2.15M 0.01%
38,504
-5,223
-12% -$287K
GPN icon
522
Global Payments
GPN
$23.9B
$2.13M 0.01%
15,766
EFX icon
523
Equifax
EFX
$22.1B
$2.1M 0.01%
7,174
+392
+6% +$109K
WMT icon
524
Walmart Inc
WMT
$901B
$2.08M 0.01%
43,092
-87,606
-67% -$4.18M
OKE icon
525
Oneok
OKE
$57.1B
$2.05M 0.01%
34,903
-6,776
-16% -$420K

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.